Planning weight maintenance after Wegovy

Read the semaglutide evidence in context

The STEP 1 extension followed a subset of adults without diabetes after 68 weeks of weekly semaglutide 2.4 mg. Both medicine and lifestyle intervention ended. One year later, participants previously receiving semaglutide had regained about two-thirds of their earlier weight loss on average. [1]

This was exploratory follow-up, not a trial of different stopping strategies. It cannot separate the effects of withdrawing medicine from withdrawing structured lifestyle support. It also cannot supply an exact regain forecast for newer oral Wegovy or the separate 7.2 mg presentation. Use the findings to justify continuing support and a review plan, rather than to conclude that every person will follow the same curve.

Be clear about why treatment is ending

Write down the main reason and what you would like help with. If side effects are the issue, explain their severity and impact. If it is cost, name the practical deadline. If pregnancy is planned, discuss timing with your prescriber well in advance. These situations need individual advice rather than the same internet “exit plan”.

Record whether you use a pen or tablets, the prescribed strength and the last dose date. Switching presentation is a prescribing decision; the milligram figures are not a conversion rule. Do not assume an old pen, a different semaglutide brand or tablets from another source will provide a safe substitute. Ask what to do if there is an unplanned treatment gap.

Replace missing structure with a workable routine

For someone who took a daily tablet, the old morning routine may have organised breakfast and other medicines. Ask a pharmacist about the ongoing timing of other prescriptions when Wegovy ends. Someone using a weekly pen may instead miss the weekly check-in that reminded them to review food and symptoms.

Choose a new cue for those useful habits. A Sunday shopping list, a planned lunch break or a regular appointment with a support service can provide structure without turning every meal into a monitoring task. Keep a small set of meals you enjoy and can afford. Review whether the routine still works as appetite changes, rather than trying to eat exactly as you did at the point of maximum appetite suppression.

Watch health and function as well as weight

The STEP 1 extension also found that several cardiometabolic improvements moved back towards baseline after withdrawal. [1] Ask your clinician whether blood pressure, glucose or other health measures need follow-up in your case. A home weight graph cannot answer every question about treatment benefit.

Keep movement appropriate to your ability and discuss changes in strength or stamina. Choose goals connected to your life, such as a comfortable walk or returning to a class. If tracking weight makes you anxious or triggers restrictive eating, tell the team and agree another approach. The follow-up should make problems easier to address, not make it harder to eat or ask for help.

Decide who will help and when

NICE recommends additional support to help maintain weight loss when weight-management medication is stopped. [2] Before the last appointment, ask who provides this, when you will hear from them and how to contact the team if progress changes. Keep the details somewhere you can find without signing into an old prescribing account.

Agree what should prompt an earlier review: a persistent upward trend, difficult hunger, loss-of-control eating or return of a health problem may all be worth discussing. Do not restart at the previous dose or create a taper yourself. A clinician can review the time off treatment, side effects, current health and available options. Needing additional treatment is a reason to reassess care, not a reason to hide the change.

Questions and answers